Showing posts with label regime. Show all posts
Showing posts with label regime. Show all posts
Saturday, February 06, 2010
abstract: From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer
Note: patients enrolled between January 2006 to December 2007 "Background: The objective of the study was to evaluate completion rates and toxic effects of an i.p. chemotherapy regimen in a cross-section of nonselected patients with ovarian cancer (OC). Conclusions: The i.p. chemotherapy regimen used in a consecutive cohort of patients carries could be completed in only a small percentage of patients. Less toxic regimens with higher acceptability should be considered."
add your opinions
IP chemotherapy
,
ovarian cancer
,
regime
Subscribe to:
Posts
(
Atom
)